REDCARE PHARMACY NV |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 115.2 EUR | -1.24% |
|
-2.29% | -12.61% |
| 07:23am | REDCARE PHARMACY : UBS gives a Sell rating | ZD |
| Jun. 06 | REDCARE PHARMACY : Berenberg gives a Buy rating | ZD |
Evolution of the average Target Price on Redcare Pharmacy NV
Price target over the last 5 years
History of analyst recommendation changes
a9af421ea169f5532b0e9.VA_c9FSCyLkn2usRCRJQ1xIUSkIH3NnATXIb_qKhV64.F0eEhTnykepRvY1IXCI0r1FELRRGjI6jez5Qh9qRIuMhYI-GC_Gh4EOzhA~618c2eb2468ef9c2cc88ffeb706015ac
More recommendations
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
116.7
EUR
Average target price
149.4
EUR
Spread / Average Target
+28.03%
High Price Target
190
EUR
Spread / Highest target
+62.81%
Low Price Target
86
EUR
Spread / Lowest Target
-26.31%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Redcare Pharmacy NV
| BERENBERG | Gerhard Orgonas |
| JEFFERIES | Martin Comtesse |
| DEUTSCHE BANK RESEARCH | Jan Koch |
| HAUCK AUFHÄUSER INVESTMENT BANKING | Christian Salis |
| UBS | Olivier Calvet |
| BAADER BANK | Volker Bosse |
| WARBURG RESEARCH | Michael Heider |
| MORGAN STANLEY | Robert Davies |
| CREDIT SUISSE | Olivier Calvet |
| BANK OF AMERICA (BOFA) | Maria-Laura Adurno |
| BARCLAYS | Otto Sieber |
| HAUCK AUFHÄUSER LAMPE | Christian Salis |
| KEPLER CHEUVREUX | Olivier Calvet |
| HAUCK & AUFHÄUSER | Christian Salis |
| DEUTSCHE BANK | Uwe Schupp |
| CITIGROUP | Natasha Brilliant |
| MAINFIRST | Daniel Grigat |
| COMMERZBANK | Andreas Riemann |
Trading Rating
Investor Rating
ESG Refinitiv
B
EPS Revisions
- Stock Market
- Equities
- RDC Stock
- Consensus Redcare Pharmacy NV
